Loxoribin, a TLR7 ligand, inhibited tumor growth in xenograft models of colon and lung cancers, and these anti-tumor effects were mediated by increased CD4+T cell proliferation and reversal of Treg-mediated immunosuppression via dendritic cells (DCs) [16]. The gene discussed is CD4; the disease is neoplasm.